ScoreWhy is Jiangxi Synergy Pharmaceutical Co., Ltd. ?
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 11.61% and Operating profit at -8.79% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 6.92% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 11.61% and Operating profit at -8.79% over the last 5 years
3
Negative results in Mar 26
- NET PROFIT(HY) At CNY 7.9 MM has Grown at -74.95%
- OPERATING CASH FLOW(Y) Lowest at CNY 106.1 MM
- ROCE(HY) Lowest at 3.02%
4
With ROE of 2.97%, it has a expensive valuation with a 0.49 Price to Book Value
- Over the past year, while the stock has generated a return of -14.52%, its profits have fallen by -15.4%
- At the current price, the company has a high dividend yield of 2.9
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -14.52% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jiangxi Synergy Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Jiangxi Synergy Pharmaceutical Co., Ltd.
-18.71%
-0.98
30.56%
China Shanghai Composite
0.9%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.61%
EBIT Growth (5y)
-8.79%
EBIT to Interest (avg)
9.33
Debt to EBITDA (avg)
3.41
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.25
Tax Ratio
2.75%
Dividend Payout Ratio
22.99%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.81%
ROE (avg)
6.92%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
37
Industry P/E
Price to Book Value
1.11
EV to EBIT
56.80
EV to EBITDA
20.31
EV to Capital Employed
1.09
EV to Sales
3.75
PEG Ratio
NA
Dividend Yield
1.28%
ROCE (Latest)
1.92%
ROE (Latest)
2.97%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-22What is not working for the Company
PRE-TAX PROFIT(Q)
At CNY 2.55 MM has Fallen at -86.33%
NET PROFIT(Q)
At CNY 5.73 MM has Fallen at -67.61%
NET SALES(HY)
At CNY 383.16 MM has Grown at -10.03%
ROCE(HY)
Lowest at 1.66%
INTEREST(Q)
At CNY 2.58 MM has Grown at 10.82%
RAW MATERIAL COST(Y)
Grown by 25.13% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.94 times
Here's what is not working for Jiangxi Synergy Pharmaceutical Co., Ltd.
Pre-Tax Profit
At CNY 2.55 MM has Fallen at -86.33%
over average net sales of the previous four periods of CNY 18.63 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 5.73 MM has Fallen at -67.61%
over average net sales of the previous four periods of CNY 17.7 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 2.58 MM has Grown at 10.82%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Net Sales
At CNY 383.16 MM has Grown at -10.03%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Debtors Turnover Ratio
Lowest at 5.94 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 25.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Non Operating Income
Highest at CNY 0.82 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
Footer loading
